Atrowok 0.60Mg Injection
Atrowok 0.60Mg Injection is used as a preoperative medication to inhibit salivation and secretions; treatment of sinus bradycardia; treatment of exercise-induced bronchospasm; antidote for organophosphate pesticide poisoning; to produce mydriasis and cycloplegia for examination of the retina and optic disc and accurate measurement of refractive errors; uveitis.
Atrowok 0.60Mg Injection falls under the group of medicines known as dopamine-receptor antagonists. It is used in patients taking chemotherapy to decrease the risk of any infections. It provides relief in case of migraines and heartburn. It may also be used before any surgery to decrease saliva production and to prevent airway secretions.
It treats diabetes and muscle spasms in stomach and other organs. By raising the stem cells count, it treats the problem of low white blood cell count. Atrowok 0.60Mg Injection is also helpful for the patients receiving radiation as it increases the formation of neutrophils in the bone marrow.
Don’t use this drug if you’re allergic to it, or have sickle-cell disease. Patients suffering from Parkinson’s disease, epilepsy or those having a history of breast cancer are not recommended to use this medicine. It should only be used by pregnant women and breastfeeding women, if no alternative is found. Using filgrastim-sndz, tbo-filgrastim or pegfilgrastim is not recommended while using Atrowok 0.60Mg Injection.
It is introduced into the body either by injecting it into the vein or under the skin. Dosage depends on the health conditions of the patients and can vary from once daily to four times a day before each meal and once before going to bed.
Take exactly as directed, 30 minutes before meals. Maintain adequate hydration (2-3 L/day of fluids unless instructed to restrict fluid intake). Void before taking medication. You may experience dizziness, blurred vision, sensitivity to light (use caution when driving or engaging in tasks requiring alertness until response to drug is known)
Symptoms of overdose include dilated, unreactive pupils; blurred vision; hot, dry flushed skin; dryness of mucous membranes; difficulty in swallowing, foul breath, diminished or absent bowel sounds, urinary retention, tachycardia, hyperthermia, hypertension, increased respiratory rate.
The medicine is useful against the following conditions:
Is It safe with alcohol?No interaction found
Are there any pregnancy warnings?Atrowok 0.60Mg Injection is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Are there any breast-feeding warnings?Atrowok 0.60Mg Injection is probably unsafe to use during breastfeeding. Please consult your doctor.
Is it safe to drive while on this medicine?Patients should not drive or operate machinery .
Does this affect kidney function?Contraindicated in renal impairment.
Does this affect liver function?There is no data available. Please consult doctor before consuming the drug.
Are there any missed dose instructions?If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Are there any overdose instructions?Seek emergency medical treatment or contact the doctor in case of an overdose.
This medication belongs to the anticholinergic class of medicine. It works by blocking contraction of the circular pupillary sphincter muscle, which leads to mydriasis. This action is normally stimulated by the release of Ach (Acetylcholine), it thereby allowing the radial dilator muscle of iris to contract and dilate the pupil.
Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.
Interaction with Medicine
- Phenothiazine and TCAs may increase anticholinergic effects when used concurrently.
- Sympathomimetic amines may cause tachyarrhythmias; avoid concurrent use.
Interaction with Disease
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.